ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Toxicon
Volume 29, Issue 1, 1991, Pages 134-138
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Purchase PDF (325 K)

Article Toolbox
 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/0041-0101(91)90047-U    
How to Cite or Link Using DOI (Opens New Window)

Copyright © 1990 Published by Elsevier Ltd.

Short Communication

Effect of route of exposure and repeated doses on the acute toxicity in mice of the cyanobacterial nicotinic alkaloid anatoxin-a

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

D.K. Stevens1 and R.I. Krieger2

1Pharmacology/Toxicology Program, College of Pharmacy, Washington State University, Pullman, WA 99164, USA

2Department of Food and Agriculture, Worker Health and Safety Branch, 1220 N Street, Sacramento, CA 95814, U.S.A.


Received 5 June 1990; 
accepted 14 August 1990. 
Available online 8 November 2002.

Abstract

Anatoxin-a (ANTX-a) is a potent nicotinic cholinergic alkaloid produced by some toxigenic strains of cyanobacteria. We have examined i.p. and oral ld50 values of two ANTX-a producing Anabaena sp. and synthetic (+)-ANTX-a in outbred Swiss Webster mice. All three appeared equivalent by i.p. injection, but Anabaena flos-aquae NRC-44-1 was approximately twice as potent orally as the other two. Additionally, we were unable to demonstrate development of any biologically significant tolerance to acute ANTX-a exposure using two different repeated dose regimens.


Toxicon
Volume 29, Issue 1, 1991, Pages 134-138
 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.